Aurigny hopes to submit its proposal in February, while the Chair of Alderney's Economic Development Committee says air links ...
Truist raised the firm’s price target on Protagonist Therapeutics (PTGX) to $110 from $88 and keeps a Buy rating on the shares. 2026 is expected ...